Patterns of fractionation for patients with T2N0M0 glottic larynx cancer undergoing definitive radiotherapy in the United States

External beam radiotherapy (EBRT) offers an effective definitive intervention with the promise of anatomic and functional preservation to patients with early-stage larynx cancer [1–4]. While conventional fractionation (CFxn) at 1.8–2.0 Gray (Gy) per day has been the predominant schedule in most series, developments in radiobiology [5–7] have sparked interest in alternative fractionation schedules as a means of improving local control.

http://ift.tt/2vJzZ08